UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047715
Receipt number R000054404
Scientific Title A retrospective study to evaluate a TG18-advocated criterion of diagnosis and operation for patients with acute cholecystitis
Date of disclosure of the study information 2022/05/11
Last modified on 2022/05/25 10:49:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study to evaluate a TG18-advocated criterion of diagnosis and operation for patients with acute cholecystitis

Acronym

TG18 evaluation study

Scientific Title

A retrospective study to evaluate a TG18-advocated criterion of diagnosis and operation for patients with acute cholecystitis

Scientific Title:Acronym

A retrospective study to evaluate a TG18-advocated criterion of diagnosis and operation for patients with acute cholecystitis

Region

Japan


Condition

Condition

Acute cholecystitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate TG18 advocate criterion of diagnosis and operation focused on elderly AC.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of undiagnosable AC using diagnostic criteria in TG18.

Key secondary outcomes

The rates of unfit for surgery based on ASA-PS and CCI, and clinical consequences at discharge.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) AC confirmed by clinical course, PTGBD, ETGBD, or Lap-C.

Key exclusion criteria

(1) Other diagnoses confirmed after admission.(2) missing date of valuables of interest.

Target sample size

217


Research contact person

Name of lead principal investigator

1st name Tesshin
Middle name
Last name Ban

Organization

Gamagori City Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

443-8501

Address

1-1 Mukaida, Hirata, Gamagori, Aichi, 443-8501, Japan

TEL

0533662200

Email

venzosan0204@gmail.com


Public contact

Name of contact person

1st name Tesshin
Middle name
Last name Ban

Organization

Gamagori City Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

443-8501

Address

1-1 Mukaida, Hirata, Gamagori, Aichi, 443-8501, Japan

TEL

0533662200

Homepage URL


Email

venzosan0204@gmail.com


Sponsor or person

Institute

Gamagori City Hospital

Institute

Department

Personal name



Funding Source

Organization

Gamagori City Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gamagori City Hospital

Address

1-1 Mukaida, Hirata, Gamagori, Aichi, 443-8501, Japan

Tel

0533662200

Email

venzosan0204@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

209

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 04 Month 21 Day

Date of IRB

2022 Year 02 Month 21 Day

Anticipated trial start date

2022 Year 04 Month 21 Day

Last follow-up date

2022 Year 05 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study


Management information

Registered date

2022 Year 05 Month 11 Day

Last modified on

2022 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054404


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name